Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
NPJ Genomic Medicine|September 13, 2022
Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasetsHuiwen Che, Tatjana Jatsenko, Lore Lannoo, et al.
Chest|April 3, 2018
Diagnostic Ability of a Dynamic Multidisciplinary Discussion in Interstitial Lung Diseases: A Retrospective Observational Study of 938 CasesLaurens J De Sadeleer, Caressa Meert, Jonas Yserbyt, et al.
Annals of the Rheumatic Diseases|February 19, 2024
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohortIoannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
Frontiers in Immunology|July 26, 2023
Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cellsKris Covens, Bert Verbinnen, Britt G de Jong, et al.
Annals of the Rheumatic Diseases|June 21, 2020
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patientsLorenzo Beretta, Guillermo Barturen, Barbara Vigone, et al.
Acta Clinica Belgica|September 12, 2017
Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosisKarin Melsens, Els Vandecasteele, Ellen Deschepper, et al.
Cell Reports|October 12, 2022
Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanismFlora Magnotti, Daria Chirita, Sarah Dalmon, et al.
Annals of the Rheumatic Diseases|August 19, 2019
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrualSerena Fasano, Antonella Riccardi, Valentina Messiniti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group StudyVeronika K Jaeger, Gabriele Valentini, Eric Hachulla, et al.
The Lancet. Rheumatology|January 22, 2024
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trialOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Pageof 10